Pacs Group Inc

Aktienanalyse zu Pacs Group Inc (PACS)

$46.910

-0.826 (-1.76%)Zum Schluss

Loading chart…
Hoch
47.890
Eröffnung
47.890
Volumengewichteter Durchschnittskurs
47.03
Volumen
958.07K
Marktkap.
—
Tief
46.290
Umsatz
45.06M
EV/EBITDA, TTM
18.70

PACS Group, Inc. is a holding company. The Company, through its subsidiaries, is engaged in providing various skilled nursing facilities (SNF) and assisted living facilities (ALF) services. It provides senior care, assisted living, and independent living options in its communities. It operates 321 post-acute care facilities across 17 states serving over 31,700 patients daily. Its post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company also provides independently operated facilities with technology, support, and back-office services.

pacs.com

KI-Analyse of Pacs Group Inc (PACS)

Kaufen

Pacs Group Inc is a good buy right now due to its strong recent performance and positive financial outlook. The current price is $46.91, with a forward P/E of 15.528, indicating potential for growth compared to its earnings. Additionally, the company reported a significant year-over-year revenue increase of 9.1% in Q2 2026, reaching $1.43 billion, and raised its full-year revenue guidance to between $5.75 billion and $5.85 billion. The main risk is the RSI of 74.549, suggesting the stock may be overbought in the short term, but the overall fundamentals and analyst sentiment support a buy.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Pacs Group Inc (PACS) beträgt 15.53, verglichen mit dem 5-Jahres-Durchschnitt von 12.94.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
12.94
Aktuelles P/E
15.53
Überbewertet
18.88
Unterbewertet
7.00

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
6.35
Aktuelles EV/EBITDA
18.70
Überbewertet
32.98
Unterbewertet
-20.29

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
0.83
Aktuelles P/S
1.16
Überbewertet
1.18
Unterbewertet
0.47

Whales, die PACS halten

C

Cohen & Steers Capital Management, Inc.

+ HältPACS

-4.97%

3-Monats-Rendite

Event-Zeitleiste

2026-10-05 (ET)

05:30:00

Omega Healthcare Transfers 32 Nursing Facilities in Florida, Rent Increases by $26.1M

2026-09-21 (ET)

16:30:00

PACS Group Chief Legal Officer John Mitchell Retires, Patrick J. Murphy to Succeed

2026-09-01 (ET)

16:30:00

Pacs Group Acquires 32 Skilled Nursing Facilities in Florida

2026-08-04 (ET)

17:00:00

Company Reports Q2 Revenue of $1.43B, Exceeding Expectations

17:00:00

Company Raises 2026 Revenue Outlook to $5.75B-$5.85B

News

PACS FAQ – beantwortet von Alphio AI

PACS Group, Inc. is a holding company. The Company, through its subsidiaries, is engaged in providing various skilled nursing facilities (SNF) and assisted living facilities (ALF) services. It provides senior care, assisted living, and independent living options in its communities. It operates 321 post-acute care facilities across 17 states serving over 31,700 patients daily. Its post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company also provides independently operated facilities with technology, support, and back-office services. It operates in the Healthcare sector.

Pacs Group Inc is a good buy right now due to its strong recent performance and positive financial outlook. The current price is $46.91, with a forward P/E of 15.528, indicating potential for growth compared to its earnings. Additionally, the company reported a significant year-over-year revenue increase of 9.1% in Q2 2026, reaching $1.43 billion, and raised its full-year revenue guidance to between $5.75 billion and $5.85 billion. The main risk is the RSI of 74.549, suggesting the stock may be overbought in the short term, but the overall fundamentals and analyst sentiment support a buy.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln